Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial

Copyright © 2023. Published by Elsevier B.V..

BACKGROUND: SHIP-CT showed that 48-week treatment with inhaled 7% hypertonic saline (HS) reduced airway abnormalities on chest CT using the manual PRAGMA-CF method relative to isotonic saline (IS) in children aged 3-6 years with cystic fibrosis (CF). An algorithm was developed and validated to automatically measure bronchus and artery (BA) dimensions of BA-pairs on chest CT. Aim of the study was to assess the effect of HS on bronchial wall thickening and bronchial widening using the BA-analysis.

METHODS: The BA-analysis (LungQ, version 2.1.0.1, Thirona, Netherlands) automatically segments the bronchial tree and identifies the segmental bronchi (G0) and distal generations (G1-G10). Dimensions of each BA-pair are measured: diameters of bronchial outer wall (Bout), bronchial inner wall (Bin), bronchial wall thickness (Bwt), and artery (A). BA-ratios are computed: Bout/A and Bin/A to detect bronchial widening and Bwt/A and Bwa/Boa (=bronchial wall area/bronchial outer area) to detect bronchial wall thickening.

RESULTS: 113 baseline and 102 48-week scans of 115 SHIP-CT participants were analysed. LungQ measured at baseline and 48-weeks respectively 6,073 and 7,407 BA-pairs in the IS-group and 6,363 and 6,840 BA-pairs in the HS-group. At 48 weeks, Bwt/A (mean difference 0.011; 95%CI, 0.0017 to 0.020) and Bwa/Boa (mean difference 0.030; 95% 0.009 to 0.052) was significantly higher (worse) in the IS-group compared to the HS-group representing more severe bronchial wall thickening in the IS-group (p=0.025 and p=0.019 respectively). Bwt/A and Bwa/Boa decreased and Bin/A remained stable from baseline to 48 weeks in the HS while it declined in the IS-group (all p<0.001). There was no difference in progression of Bout/A between two treatment groups.

CONCLUSION: The automatic BA-analysis showed a positive impact of inhaled HS on bronchial lumen and wall thickness, but no treatment effect on progression of bronchial widening over 48 weeks.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:22

Enthalten in:

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 22(2023), 5 vom: 22. Sept., Seite 916-925

Sprache:

Englisch

Beteiligte Personen:

Chen, Yuxin [VerfasserIn]
Lv, Qianting [VerfasserIn]
Andrinopoulou, Eleni-Rosalina [VerfasserIn]
Gallardo-Estrella, Leticia [VerfasserIn]
Charbonnier, Jean-Paul [VerfasserIn]
Caudri, Daan [VerfasserIn]
Davis, Stephanie D [VerfasserIn]
Rosenfeld, Margaret [VerfasserIn]
Ratjen, Felix [VerfasserIn]
Kronmal, Richard A [VerfasserIn]
Stukovsky, Karen D Hinckley [VerfasserIn]
Stick, Stephen [VerfasserIn]
Tiddens, Harm A W M [VerfasserIn]
on behalf the SHIP-CT study group [VerfasserIn]

Links:

Volltext

Themen:

Artificial intelligence
Bronchial wall thickening
Computed tomography
Cystic fibrosis
Hypertonic saline
Journal Article
Randomized Controlled Trial
Saline Solution, Hypertonic
Structural airway disease

Anmerkungen:

Date Completed 28.11.2023

Date Revised 24.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jcf.2023.05.013

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357482573